FreeStyle Libre 3 and 3 Plus are continuous glucose monitoring devices indicated for the management of diabetes in patients aged 4 years and older.

Around 1 million drivers have been given a key health condition update from the Department for Transport. Officials responded ...

Abbott has been hit with a slew of complaints from the FDA in a warning letter related to its continuous glucose monitor (CGM ...

The Department for Transport has clarified the blood sugar monitoring process for around 1 million insulin-dependent drivers ...

Study highlights GLP-1 companion effects, underscoring capability of Brightseed’s AI platform to identify and launch ...

This is now a Class I recall, meaning that the use of these continuous glucose monitoring systems could cause serious health ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

In 2025, New York state and federal courts issued a series of consequential decisions shaping the litigation landscape for pharmaceutical, ...

Asian shares slipped Thursday after more drops for technology stocks weighed on Wall Street. U.S. futures edged higher and oil prices sank more than $1 a barrel. Tokyo's Nikkei 225 shed 0.7% to 53,935 ...

NEW YORK (AP) — More drops for technology stocks weighed on Wall Street Wednesday. The S&P 500 fell 0.5% for its fifth modest loss in the last six days. The Dow Jones Industrial Average rose 260 ...

Southeast Asia Medical Wearable Devices Market was valued at ~USD 2,080.65 million in 2024 grow at a strong CAGR of ...